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Viral replication and capsid assembly in the viruses in the order Picornavirales requires polyprotein
proteolytic processing by 3C or 3C-like (3CL) proteases. We identiﬁed and characterized the 3CL
protease of Ectropis obliqua virus (EoV) of the newly established family Iﬂaviridae (order Picornavirales).
The bacterially expressed EoV 3CL protease domain autocatalytically released itself from larger
precursors by proteolytic cleavage, and cleavage sites were determined via N-terminal sequencing of
the cleavage products. This protease also mediated trans-proteolytic activity and cleaved the
polyprotein at the same speciﬁc positions. Moreover, we determined the critical catalytic residues
(H2261, D2299, C2383) for the protease activity, and characterized the biochemical properties of EoV
3CL and its responses to various protease inhibitors. Our work is the ﬁrst study to identify an iﬂaviral
3CL protease and further characterize it in detail and should foster our understanding of EoV and other
iﬂaviruses.
& 2012 Elsevier Inc. All rights reserved.Introduction
The order Picornavirales comprises ﬁve families of positive-
strand RNA viruses (Dicistroviridae, Picornaviridae, Marnaviridae,
Secoviridae, and Iﬂaviridae) that share several common features.
Their polyproteins contain a conservative helicase–protease–
polymerase (Hel–Pro–Pol) module of core replication domains
and capsid proteins (CPs) (Le Gall et al., 2008). These groups of
small single-stranded RNA viruses infect different vertebrate,
invertebrate, and plant hosts and are responsible for a variety of
human, animal, and plant diseases.
The proteolytic processing of viral polyproteins is a crucial step
in genome replication and CPs assembly in the order Picornavir-
ales, whose genome generally translates a large precursor
polyprotein. After translation, the viral precursor polyprotein
is proteolytically cleaved to generate mature functional viral
proteins (Dougherty and Semler, 1993). This maturation process
is usually mediated by (more than one) proteases, and a 3C (for
the family Picornaviridae) or 3C-like (3CL) protease (for other
families) plays a central role in the cleavage of the viral precursor
polyprotein (Le Gall et al., 2008; Palmenberg, 1990). To date, 3C
and 3CL proteases have been extensively studied in several
viruses in the order Picornavirales, particularly hepatitis A virusll rights reserved.
yyhu@whu.edu.cn (Y. Hu).(HAV), poliovirus (PV), human rhinovirus (HRV), encephalomyo-
carditis virus (EMCV), human enterovirus 71 (EV71), and foot-
and-mouth disease virus (FMDV) in the family Picornaviridae
(Bablanian and Grubman, 1993; Bonderoff et al., 2008; de
Breyne et al., 2008; Ghildyal et al., 2009; Goodwin et al., 2009;
Harmon et al., 1992; Lawson et al., 1999; Lu et al., 2011; Rivera
and Lloyd, 2008). Furthermore, the crystallographic structures of
picornaviral 3C proteases from HRV, HAV, FMDV, and EV71 have
been determined, which facilitates the identiﬁcation of the active
sites of these 3C proteases. The functional and structural studies
of 3C or 3CL proteases have revealed that most of them are
cysteine proteases and contain the chymotrypsin (two b-barrel)
fold; therefore, they are also called ‘‘chymotrypsin-like proteases’’
(CHLPro) (Allaire et al., 1994; Cui et al., 2011; Gorbalenya et al.,
1986; Malcolm, 1995; Matthews et al., 1994; Sweeney et al.,
2007).
Within the order Picornavirales, the family Iﬂaviridae is a new
member classiﬁed by the International Committee on Taxonomy of
Viruses (2009) (http://www.ictvonline.org/virusTaxonomy.asp?ver
sion=2009) and this family currently includes the sole genus
Iﬂavirus (Christian et al., 2005; van Oers, 2010). In addition, the
viral structure and genomic organization of iﬂaviruses are quite
similar to those of the viruses of the family Picornaviridae (Le Gall
et al., 2008). Ectropis obliqua virus (EoV) was initially identiﬁed by
our group in 2000 and was classiﬁed as a member of the Iﬂaviridae
family in January 2010 (van Oers, 2010; Wang et al., 2004). EoV is
an insect positive-strand RNA virus that leads to a lethal granulosis
Fig. 1. (A) The map of the EoV genome. The long box represents the single open reading frame with different conserved protein domains as indicated. (B) The amino acid
sequence alignment of the putative 3CL protease domain of EoV compared with those of the other iﬂaviruses (VDV-1, DWV, SBV, PnV, and IFV), cripavirus (CrPV), and three
picornaviruses (PV, ECMV, and HAV) Multiple sequence alignments were generated using ClustalX. The genomic position of the ﬁrst amino acid of each aligned sequence is
indicated, with those of partial sequences shown in brackets and the conserved amino acids identiﬁed by asterisks.
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is an important agricultural pest that can seriously damage tea
leaves. To date, the genomic RNA of EoV has been cloned as full-
length cDNA and completely sequenced. The genome of EoV
consists of 9394 nucleotides (nts) excluding the poly(A) tail and
contains a single large open reading frame (nt 391–9351)
encoding a polyprotein of 2987 amino acids. In this polyprotein,
structural and nonstructural proteins are located at its N- and
C-terminal regions respectively, and the conservative Hel–Pro–
Pol and CPs domains have been identiﬁed as well (Fig. 1A) (Wang
et al., 2004). In the 50 untranslated region (50 UTR), an internal
ribosome entry site (IRES) has been shown to play an essential
role in mediating EoV cap-independent translation (Lu et al.,
2007, 2006). The RNA-dependent RNA polymerase (RdRp) activ-
ity of EoV has also been identiﬁed (Lin et al., 2010). In addition to
EoV, the family Iﬂaviridae comprises other invertebrate viruses,
such as infectious ﬂacherie virus (IFV) of the silkworm, Sacbrood
virus (SBV) of the honeybee, Perina nuda virus (PnV), deformed
wing virus (DWV), and Varroa destructor virus-1 (VDV-1), as well
as some tentative members like slow bee paralysis virus (SBPV)
and Nasonia vitripens virus (NvV) (Christian et al., 2005; van Oers,
2010).
On the basis of the amino acid sequences, putative cysteine 3CL
protease domains have been predicted in all the members of the
family Iﬂaviridae (Ghosh et al., 1999; Isawa et al., 1998; Lanzi et al.,
2006; Ongus et al., 2004; Wang et al., 2004; Wu et al., 2002). The
putative EoV cysteine protease motif GXCG is located in the
C-terminal half of the polyprotein precursor, upstream of the RdRp
domain, and the putative catalytic triad of H2261, D2299, and
C2383 is also conserved in EoV and other iﬂaviruses (Fig. 1B) (Wang
et al., 2004). Despite the importance of 3C and 3CL proteases in
viruses in the order Picornavirales (Le Gall et al., 2008), 3CL protease
activity in iﬂaviruses has not been formally determined, and
consequently, the molecular mechanisms of 3CL-mediated cleavage
of iﬂaviral polyproteins have not yet been studied, which signiﬁ-
cantly limits our understanding of this new family.
In this study, we identiﬁed EoV 3CL as a cysteine protease and
conﬁrmed that the EoV 3CL protease can be released autocataly-
tically from the polyprotein in the form of a 34 kDa protein and
exhibits speciﬁc trans-cleavage activity. Moreover, via N-terminal
sequencing and mutational analyses, we have deﬁned the clea-
vage sites of the EoV 3CL protease, determined the catalytic
residues that are critical for its activity, and characterized its
biochemical properties and responses to various protease inhibi-
tors. Our study not only represents a crucial step toward under-
standing the mechanism of EoV polyprotein proteolytic
processing, but also suggests future directions for the study of
3CL proteases, polyprotein processing, and viral replication of
other iﬂaviruses.Results
Autocatalytic processing activity of EoV 3CL protease in E. coli
To determine whether the putative EoV 3CL protease domain
can autocatalytically release itself from ﬂanking domains, we
expressed the two fusion proteins, His-Pro2160–2680-Flag and His-
Pro2026–2738-Flag, which contain amino acids 2160–2680 and
2026–2738 of the EoV polyprotein, respectively (Fig. 2A). Both
fragments covered the entire putative 3CL protease region as well
as various portions of the neighboring domains. They were linked
to the pET32a vector with a His-tag at the N-terminus and an
inserted Flag-tag at the C-terminus. After being expressed in
E. coli, the proteins were then subjected to Western blot analyses
with various antibodies.
Western blotting with anti-His monoclonal antibody revealed
an approximately 78-kDa band corresponding to the intact
His-Pro2160–2680-Flag in addition to two cleavage products of
around 23 kDa and 57 kDa (Fig. 2B, lane 1). Meanwhile, we
observed an approximately 99-kDa band corresponding to the
intact His-Pro2026–2738-Flag fusion protein as well as two more
bands around 38 kDa and 72 kDa (Fig. 2B, lane 2). The cleavage
products of His-Pro2160–2680-Flag and His-Pro2026–2738-Flag with
molecular weights of around 23 kDa and 38 kDa, respectively, were
presented in relatively smaller amounts than other proteins, and
are believed to be the products that were autocatalytically cleaved
from the N-terminal of the putative 3CL protease region in both
His-Pro2160–2680-Flag and His-Pro2026–2738-Flag fusion proteins. Of
note, both fusion proteins included a 19-kDa amino acid sequence
from the pET32a vector (Fig. 2A, black box). On the other hand, the
57-kDa and 72-kDa protein bands should correspond to the
C-terminal cleavage products of both fusion proteins. The detection
of intact His-Pro2160–2680-Flag and His-Pro2026–2738-Flag proteins
(around 78 kDa and 99 kDa, respectively) in these experiments
indicates that cleavage of the proteins was not completed.
The cleavage products were also examined via Western
blotting with anti-Flag monoclonal antibody. In addition to the
intact fusion proteins (around 78 kDa and 99 kDa), two cleavage
products of around 55 kDa and 21 kDa were observed for
His-Pro2160–2680-Flag (Fig. 2C, Lane 1), while for His-Pro2026–2738-Flag,
two cleavage products of around 61 kDa and 27 kDa were clearly
detected (Fig. 2C, lane 2). The 21-kDa and 27-kDa bands should
be the C-terminal cleavage products of His-Pro2160–2680-Flag and
His-Pro2026–2738-Flag, respectively, whereas the 55-kDa and 61-kDa
bands should be the cleavage products from the N-terminal of the
putative 3CL protease region (Fig. 2A).
Moreover, to exclude the possibility that the cleavage of both
fusion proteins was mediated by any bacterially derived protease,
the putative core conserved active residue GXC(2383)G (Fig. 1B)
Fig. 2. Cleavage activity of the putative EoV 3CL protease. (A) Left: Schematic illustrations of the recombinant fusion proteins His-Pro2160–2680-Flag and His-Pro2026–2738-
Flag and their site-speciﬁc mutants His-Pro2160–2680-Flag(C2383A) and His-Pro2026–2738-Flag(C2383A). The fusion proteins are depicted as bars. Arrows point to the
putative boundaries of each cleavage product, and amino acid pairs probably forming processing sites with the numbers representing the positions indicated below the
bars. The molecular weights of the cleavage products are indicated between the arrows. Right: The fusion proteins and their cleavage products were subjected to 12% SDS-
PAGE and then Western blot analysis with anti-His or anti-Flag monoclonal antibody. The molecular weights of the detected cleavage products are indicated below the
primary antibodies (anti-His and anti-Flag). (B) Western blots with anti-His antibody. Lane M, molecular weight marker; Lane 1, His-Pro2160–2680-Flag; Lane 2, His-Pro2026–
2738-Flag. (C) Western blots with anti-Flag antibody. Lane M, molecular weight marker; Lane 1, His-Pro2160–2680-Flag; Lane 2, His-Pro2026–2738-Flag. (D) Western blots with
the mutants. Lane M, molecular weight marker; Lane 1, His-Pro2160–2680-Flag(C2383A); Lane 2, His-Pro2026–2738-Flag(C2383A); Lane 3, His-Pro2160–2680-Flag(C2383A); Lane
4, His-Pro2026–2738-Flag (C2383A). Lanes 1 and 2 were blotted with anti-His antibody, and lanes 3 and 4 were blotted with anti-Flag antibody.
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processing activity of a 3CL protease. The mutants His-Pro2160–
2680-Flag(C2383A) and His-Pro2026–2738-Flag(C2383A) could not
undergo any autocatalytic cleavage, as the Western blots with
both anti-His and anti-Flag antibodies revealed only the intact
fusion proteins at their expected molecular weights (i.e., 78 kDa
and 99 kDa respectively) (Fig. 1D, lanes 1–4). Taken together,
these results indicate that EoV 3CL can release itself from
neighboring domains via the localization of 3CL protease activity
in the putative EoV 3CL region, and the predicted catalytic residue
C(2383) is indispensable for the proteolytic activity.
Further conﬁrmation of the cleavage activity of EoV 3CL via anti-3CL
polyclonal antibodies
To further conﬁrm the cleavage activity of EoV 3CL, we exam-
ined its autocatalytic processing using antibodies that speciﬁcally
recognized the EoV 3CL protease. The EoV 3CL-speciﬁc polyclonal
antibodies were obtained by immunizing rabbit with puriﬁed His-
tagged 3CL-His fusion protein, which contains the C-terminal 6xHis
tag and the predicted complete EoV 3CL region without any extra
amino acids (Fig. 3A, upper portion: 3CL-His). As shown in Fig. 3B
(lane 3), the purity of 3CL-His fusion protein puriﬁed via nickel–
nitrilotriacetic acid (Ni–NTA) was also assessed via sodium dodecyl
polyacrylamide gel electrophoresis (SDS-PAGE).
To examine the cleavage activity of EoV 3CL, we expressed four
different fusion proteins, His-Pro2160–2492, His-Pro2026–2492,
His-3C3D0 and His-Pro2160–2680-Flag in E. coli. All four fusionproteins contained the entire 3CL region; both His-Pro2160–2492
and His-Pro2026–2492 included one predicted cleavage site at the
N-terminal of EoV 3CL, His-3C3D0 included one predicted cleavage
site at the C-terminal of EoV 3CL, whereas His-Pro2160–2680-Flag
contained the two predicted cleavage sites at both N- and
C-terminals (Fig. 3A). Western blot analyses using anti-3CL poly-
clonal antibodies revealed that His-Pro2160–2492 was processed into
two products, a 57-kDa band corresponding to the intact His-
Pro2160–2492 and a 34-kDa band corresponding to the predicted
3CL protease (Fig. 3C, lane 2). Similarly, His-Pro2026–2492 was
processed into two products that corresponded to the intact His-
Pro2026–2492 (72 kDa) and the 3CL protease (34 kDa) (Fig. 3C, lane 3).
On the other hand, the bacterial expression of His-Pro2160–2680-
Flag yielded four protein bands. In addition to the intact fusion
protein (78 kDa), the 54-kDa and 57-kDa band corresponded to
the cleavage product generated from the single cleavage at the N-
or C-terminal of the 3CL domain, respectively, and the 34-kDa
band corresponded to the cleavage product generated from the
double cleavage at both the N- and C-terminals of the 3CL domain
(Fig. 3C, lane 4). The bacterial expression of all three recombinant
fusion proteins yielded the 34-kDa products that apparently
corresponded to 3CL protease. In addition, the His-3C3D0 was
processed into two products. The 74-kDa band corresponded to
the intact His-3C3D0, while the 53-kDa band corresponded to the
cleavage product generated from the single cleavage at the
C-terminal of the 3CL domain (Fig. 3D, lane 2). Taken together,
these results conﬁrm the autocatalytic processing activity of the
EoV 3CL protease and further indicate the size of EoV 3CL.
Fig. 4. Mutational analysis of the predicted catalytic sites for EoV 3CL protease
activity. (A) The fusion proteins are depicted as bars. The sites for point mutations
are indicated. (B) The fusion proteins were subjected to Western blot analysis with
anti-3CL polyclonal antibodies. Lane M, molecular weight marker; Lane 1, 3CL-His;
Lane 2, His-Pro2026–2492(C2383-A); Lane 3, His-Pro2026–2492(H2261-A); Lane 4
His-Pro2026–2492(D2299-A). The positions for 3CL and 3CL-His are indicated.
Fig. 3. Expression and puriﬁcation of 3CL-His and conﬁrmation of the cleavage activity of EoV 3CL via anti-3CL polyclonal antibodies. (A) Schematic illustrations of the
recombinant fusion proteins 3CL-His, His-Pro2160–2492, His-Pro2026–2492, His-Pro2160–2680-Flag and His-3C3D0 . The fusion proteins are depicted as bars. The molecular
weights of the cleavage products detected with anti-3CL polyclonal antibodies are indicated. (B) Expression and puriﬁcation of 3CL-His. Lane M, molecular weight markers;
Lane 1, uninduced cell lysate; Lane 2, induced cell lysate; Lane 3, puriﬁed 3CL-His. The position of overexpressed 34-kDa 3CL-His is shown. (C) The different fusion proteins
3CL-His (Lane 1), His-Pro2160–2492 (Lane 2), His-Pro2026–2492 (Lane 3), and His-Pro2160–2680-Flag (Lane 4) were subjected to Western blot analysis with anti-3CL polyclonal
antibodies. Lane M, molecular weight marker. (D) The fusion proteins 3CL-His (Lane 1) and His-3C3D0 were subjected to Western blot analysis with anti-3CL polyclonal
antibodies. Lane M, molecular weight marker.
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mutational analyses
The EoV 3CL protease has been proposed to be a cysteine protease
containing the catalytic triad of H2261, D2299, and C2383, which is
conserved in the Iﬂaviridae family (Fig. 1B). To determine whether
these conserved residues are responsible for the autocatalytic
processing of the EoV polyprotein, we expressed the wild-type fusion
protein His-Pro2026–2492 and its mutants His-Pro2026–2492(H2261A),
His-Pro2026–2492(C2383A), and His-Pro2026–2492(D2299A) in E. coli(Fig. 4A) and then subjected them to Western blot analyses with
anti-3CL polyclonal antibodies.
Compared with the wild-type His-Pro2026–2492 (Fig. 3C, lane 3),
only one 72-kDa band at the expected molecular weight of the
intact His-Pro2026–2492(H2261A) or His-Pro2026–2492(C2383A) was
observed (Fig. 4B, lanes 2 and 3), indicating that the substitution
of H2261 or C2383 with alanine (A) could abolish the cleavage
activity of the EoV 3CL protease. These experiments were inde-
pendently repeated several times with extended reaction or
exposure time, and the same results were obtained (data not
shown). Interestingly, the autocatalytic processing activity of
His-Pro2026–2492(D2299A) was much weaker than that of wild-
type His-Pro2026–2492 (Fig. 4B, lane 4 vs. Fig. 3C, lane 3), indicating
that the D2299A substitution inhibits but does not abolish the
protease activity of EoV 3CL. The mutagenesis analyses of the EoV
3CL protease showed that the conserved H2261, D2299, and
C2383 play critical roles in EoV 3CL protease activity and
provided further conﬁrmation of the cleavage activity of EoV 3CL.Determination of the cleavage sites of EoV 3CL via N-terminal
sequencing analyses
To further characterize the proteolytic activity of the EoV 3CL
protease, we sought to determine the exact location of its
cleavage sites. To this end, the fusion protein GST-Pro2176–2677-
His, which contains amino acids 2176–2677 and covers the
complete 3CL domain and ﬂanking sequences with both cleavage
sites, was expressed (Fig. 5). After bacterial expression and
puriﬁcation for His fusion protein via Ni–NTA, the puriﬁed
products were separated via SDS-PAGE. Three proteins with
molecular weights of 82 kDa, 56 kDa, and 21 kDa were readily
detected (Fig. 5, lane 1). The 82-kDa band corresponded to the
intact fusion protein GST-Pro2176–2677-His, whereas the 56-kDa
and 21-kDa bands corresponded to the products cleaved at the
N- and C-terminals of the 3CL protease domain, respectively. The
puriﬁed cleavage products were then subjected to N-terminal
amino acid sequencing analyses.
Fig. 5. Determination of the cleavage sites of the EoV 3CL protease via N-terminal
sequencing. The fusion protein GST-Pro2176–2677-His was expressed in E. coli and
then puriﬁed. The fusion protein and its cleavage products were separated on 12%
SDS-PAGE and stained with Coomassie blue. Lane M, molecular weight marker;
Lane 1, GST-Pro2176–2677-His and cleavage products. The fusion protein and
cleavage products are depicted as a bar. The cleavage products were subsequently
subjected to N-terminal amino acid sequencing analyses, and the positions of the
determined cleavage sites are indicated below the bars.
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determined to be AQAK, which are mapped to amino acids 2193–
2196 of the EoV polyprotein, indicating that N-terminal cleavage
takes place in the E/A dipeptide at positions 2192 and 2193 (Fig. 5).
On the other hand, N-terminal sequencing of the autoprocessed
21-kDa product revealed that the sequence was SATA, which
corresponds to the amino acids 2492–2495, indicating that C-term-
inal cleavage occurs in the Q/S dipeptide at positions 2491 and 2492.
Of note, a faint band less than 56 kDa was detected; however,
N-terminal sequencing of this band was unsuccessful, and this band
may represent a bacterial contaminant. Taken together, these results
indicate that the N- and C-terminal boundaries of the EoV 3CL
protease are amino acids 2193 and 2491.
Trans-cleavage activity of the EoV 3CL protease
Various viral proteases have been showed to be able to cleave
viral polyproteins in an intermolecular manner (in trans)
(Blakeney et al., 2003; Carrier et al., 1999; Harmon et al., 1992;
Lin et al., 2004; Robel et al., 2008; Tian et al., 2009). Therefore, we
sought to determine whether EoV 3CL could intermolecularly
cleave its natural substrate, the EoV polyprotein, in trans. His-
tagged EoV 3CL protease (His-3CL) was bacterially expressed and
puriﬁed as the functional enzyme, and the protease-defective
His-3CL(C2383A) mutant was used as the negative control
(Fig. 6A). On the other hand, the puriﬁed fusion protein His-
3C3D0(C2383A) contains a cleavage site between the 3CL region
and partial 3D-like/RdRp domain and was used as the trans-
cleavage substrate. The C2383A substitution completely abolished
the 3CL protease activity in the fusion protein, thereby excluding
the possibility of any intramolecular cleavage. The trans-cleavage
products were analyzed via 12% SDS-PAGE (Fig. 6B). After 6 h
of incubation, wild-type His-3CL efﬁciently cleaved His-
3C3D0(C2383A), as the level of the 53-kDa band corresponding
to both His-3CL and the trans-cleavage product His-3CL(C2383A)
was increased and an additional 21-kDa band corresponding to
3D0 appeared (Fig. 6B, lane 4), when compared with the levels of
the same reaction mix before incubation (Fig. 6B, lane 2). As
expected, the reaction of the substrate with the active site mutant
His-3CL(C2383A) did not exhibit any cleavage (Fig. 4B, lane 3).To further conﬁrm the trans-cleavage activity of EoV 3CL, we
used His-Pro2026–2738-Flag(C2383A), which contains the cleavage
sites at both the N- and C-terminals of the 3CL domain, as the
substrate. Western blot analyses with anti-Flag antibody revealed
that wild-type His-3CL efﬁciently cleaved the fusion protein in trans
after 6 h of incubation (Fig. 6C, lane 4), whereas negative controls
(Fig. 6C, lanes 1–3) did not exhibit any cleavage products. Of note,
faint bands of about 34 kDa were observed in the reaction in the
presence or absence of wild-type His-3CL or His-3CL(C2383A)
(Fig. 4C, lanes 2–4), but these were non-speciﬁc bands, not cleavage
products. Taken together, these results indicate that our bacterially
expressed recombinant EoV His-3CL protease was enzymatically
active and able to mediate trans-cleavage activity.
After determining the trans-cleavage activity of the EoV 3CL
protease, we sought to determine whether the cleavage sites in trans
cleaved the polyprotein at the same speciﬁc positions identiﬁed in
Fig. 5. To this end, we used wild-type His-3CL as the protease,
and we used the fusion proteins His-Pro2160–2680-Flag(C2383A), His-
Pro2160–2680-Flag(E2193A-C2383A), His-Pro2160–2680-Flag (C2383A-
Q2492A), and His-Pro2160–2680-Flag(E2193A-C2383A-Q2492A) as the
trans-cleavage substrates. All four fusion proteins are protease
defective (C2383A), and the last three fusion proteins contain the
point mutation(s) in one or both of the identiﬁed cleavage sites of
EoV 3CL.
The trans-cleavage products of His-Pro2160–2680-Flag(C2383A)
were subjected to Western blot analysis with anti-Flag antibody
(Fig. 6D, lane 5), revealing two cleavage products of about 55 kDa and
21 kDa, a result similar to the cleavage results obtained previously
(Fig. 2C, lane 1). The trans-cleavage assay using His-Pro2160–2680-
Flag(C2383A-Q2492A) or His-Pro2160–2680-Flag(E2193A-C2383A) as
the substrate revealed only one cleavage product of about 55 kDa
(Fig. 6D, lane 3) or 21 kDa respectively (Fig. 6D, lane 4) besides the
intact fusion protein. Moreover, for His-Pro2160–2680-Flag(E2193A-
C2383A-Q2492A), both the cleavage sites determined via N-terminal
sequencing were mutated, and no trans-cleavage was observed when
this fusion protein was used as the substrate (Fig. 6D, lane 2). On the
basis of these results, we can conclude that the EoV 3CL protease is
active in trans, and the trans-cleavage occurs at the same positions
determined via the N-terminal sequencing analyses.
Optimal reaction conditions and the effects of protease inhibitors for
the processing activity of EoV 3CL
The data reported in the preceding sections conﬁrm that EoV 3CL
is a protease and demonstrate its processing activities. To further
characterize the biochemical properties of EoV 3CL, we examined
the 3CL protease activities under varying reaction conditions, such
as pH, temperature, and salt content, or after treatment with various
protease inhibitors. Of note, the protease activities were examined
using the previously described trans-cleavage assay with His-3CL
(2 mM) as the enzyme and His-3C3D0(C2383A) (5 mM) as the
substrate and were assessed by measuring the ratio of cleavage
products/precursor after each reaction.
The cleavage reactions were ﬁrstly performed at the different
time points from 0 to 12 h, and measured the ratios of cleavage
products/precursor (Fig. 7A). We then chose the time point of 6 h,
which is in the linear phase of the cleavage activity (Fig. 7A), for
the following experiments. The optimal pH was around 7.5, and
either a lower or higher pH impaired 3CL protease activity
(Fig. 7B), indicating that the EoV 3CL protease has a relatively
low tolerance for pH variation. The trans-cleavage assays were
conducted at different temperatures, such as 8 1C, 16 1C, 22 1C,
30 1C, 37 1C, and 48 1C. The optimal temperature was determined
to be about 22 1C (Fig. 7C).
The results of the trans-cleavage assays with different Naþ
concentrations indicated that the optimal concentration was
Fig. 6. Trans-cleavage of the EoV 3CL protease. (A) Schematic illustrations of the wild-type and mutant 3CL proteases and various substrates. (B) The substrate His-
3CD0(C2383A) was expressed in E. coli, puriﬁed via Ni–NTA chromatography, and then mock-treated for 0 h (Lane 5) or 6 h (Lane 1), incubated with His-3CL (active
protease) for 0 h (Lane 2) or 6 h (Lane 4), or incubated with His-3CL(C2383A) (inactive protease) for 6 h (Lane 3). Then, the reaction mix was subjected to 12% SDS-PAGE,
and the proteins were stained with Coomassie brilliant blue R250. Lane M, molecular weight marker. (C) The substrate His-Pro2026–2738-Flag(C2383A) was incubated with
His-3CL (active) for 0 h (Lane 1) or 6 h (Lane 4), incubated with His-3CL(C2383A) (inactive) for 6 h (Lane 3), or mock-treated for 6 h (Lane 2). The reaction mixtures were
separated via 12% SDS-PAGE and then subjected to Western blot analysis with anti-Flag antibody. The arrow indicates the position of the fusion protein or cleavage
products. (D) Active His-3CL was used to treat different substrates, including His-Pro2160–2680-Flag(C2383A) for 0 h (Lane 1) and for 6 h (Lane 5) and His-Pro2160–2680-
Flag(E2193A-C2383A-Q2492A) (Lane 2), His-Pro2160–2680-Flag (C2383A-Q2492A) (Lane 3), and His-Pro2160–2680-Flag(E2193A-C2383A) (Lane 4) for 6 h. The reaction
mixtures were separated via 12% SDS-PAGE and then subjected to Western blot analysis with anti-Flag antibody.
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sensitive to Naþ . A high concentration of Naþ (about 200 mM)
strongly inhibited 3CL protease activity, but a concentration
lower than 50 mM was also not ideal for enzyme activity. Then,
we examined the effects of various divalent cations on the
protease activity. To this end, the reaction was supplemented
with 5 mM of HgCl2, CuCl2, MgCl2, CaCl2, or ZnCl2. Although MgCl2
or CaCl2 did not affect protease activity, Cu
2þ , Zn2þ , and Hg2þ
decreased protease activity remarkably relative to the level of
activity before the extra cations were added.
Finally, we examined a group of known inhibitors of cysteine
or serine protease to determine their effects on the activity of the
EoV 3CL protease (Fig. 7F). The cysteine 3C and 3CL proteases
were previously reported to be sensitive to sulfhydryl reagents
(Someya et al., 2005). As expected, 50 mM p-chloromercuribenze-
nesulfonate (PCMBS), which contains an Hg2þ within each
compound, strongly inhibited the 3CL activity. Moreover, 50 mM
methyl methanethiosulfonate (MMTS) or N-ethylmaleimide(NEM), either of which could form a covalent bond with a sulfur
atom of the cysteine residue, almost completely abolished the
protease activity of EoV 3CL. On the other hand, phenyl methyl-
sulfonylﬂuoride (PMSF), which is known as an inhibitor of serine
proteases, also inhibited EoV 3CL activity, but in a much less
efﬁcient way than did PCMBS, MMTS, and NEM, which are speciﬁc
for cysteine proteases. All these experiments were independently
repeated for three times.Discussion
Polyprotein processing is a common strategy used by many
viruses to generate functional protein products from a single open
reading frame (Palmenberg, 1990). For iﬂaviruses, such as EoV,
viral replication also involves the proteolytic processing of viral
polyprotein, and a 3CL domain was predicted to be the critical
protease in this process (Wang et al., 2004). In this study, we
Fig. 7. Optimal reaction conditions and effects of protease inhibitors for the processing activity of EoV 3CL and the ratio of cleavage products/precursor. (A) Cleavage
activity at different reaction time points (1, 2, 3, 4, 5, 6, 7, 8, 10, 12 h). Enzyme His-3CL and substrate His-3C3D0(C2383A) were incubated in a buffer of 25 mM Tris–HCl and
50 mM NaCl (pH, 7.5) at 22 1C. (B) Effects of pH on protease activity. Enzyme His-3CL and substrate His-3C3D0(C2383A) were incubated in a buffer of 25 mM Tris–HCl and
50 mM NaCl with various pH (6.0, 6.5, 7.0, 7.5, 8.0, 8.5, 9.0, and 10.0) at 22 1C for 6 h. (C) Effects of temperature on protease activity. Enzyme His-3CL and substrate His-
3C3D0(C2383A) were reacted in a buffer of 25 mM Tris–HCl and 50 mM NaCl (pH, 7.5) for 6 h at the indicated temperatures (81, 161, 221, 301, 371, and 48 1C). (D) Effects of
NaCl concentration on protease activity. Enzyme His-3CL and substrate His-3C3D0(C2383A) were reacted in the 25-mM Tris–HCl buffer (pH, 7.5) containing the indicated
concentrations (0, 25, 50, 75, 100, and 200 mM) of NaCl at 22 1C for 6 h. (E) Effects of various divalent cations (5 mM) on protease activity in the 25-mM Tris–HCl buffer
(pH, 7.5) at 22 1C for 6 h. None: reaction without extra cations. (F) Effects of various protease inhibitors on 3CL protease activity. Enzyme His-3CL and substrate His-
3C3D0(C2383A) were incubated in the 25 mM Tris–HCl buffer (pH 7.5) with 50 mM of each indicated inhibitor at 22 1C for 6 h. None: no inhibitor. The standard errors of the
means of results from three independent experiments are shown.
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autocatalytically release itself from ﬂanking sequences and to
mediate proteolytic processing in trans. Moreover, via N-terminal
sequencing and mutational analyses, we have deﬁned the two
cleavage sites of the EoV 3CL protease. Furthermore, we have
determined the catalytical residues that are critical for EoV 3CL
protease activity and characterized the biochemical properties of
EoV 3CL.
We have identiﬁed the N- and C-terminal cleavage sites for
EoV 3CL as Q/S and E/A, which are consistent with the typical
characteristics of the polyprotein substrates of many other
picornaviral 3C and 3CL proteases, namely, cleavage at Q, E/G, S,
or A (Dougherty and Semler, 1993; Palmenberg, 1990). We also
observed that proteolytic processing efﬁciency was higher at the
C-terminal site Q/S than at the N-terminal site E/A. In the cleavageassay, the C-terminal (Q/S) cleavage products were obviously
much more prominent than the N-terminal (E/A) cleavage pro-
ducts (Figs. 2B and 5); likewise, in the trans-cleavage assay,
cleavage in Q/S was more effective than in E/A (Fig. 6C, lane 4).
Consistently, most 3C and 3C-like proteases appear to prefer
glutamine (Q) to glutamic acid (E) for cleavage (Palmenberg,
1990). The speciﬁcity for glutamine has been attributed to the
ability of the carboxamide group of the glutamine to form
hydrogen bonds with two conserved amino acids (threonine,
histidine) in the substrate binding pocket of 3C and 3CL proteases
(Matthews et al., 1994).
In addition to the primary conserved amino acid sequences,
the secondary structure around the cleavage site may also be
important for the speciﬁcity of cleavage (Ypma-Wong et al.,
1988). Interestingly, we found several additional Q–S (Q–G or
S. Ye et al. / Virology 428 (2012) 136–145 143Q–A) and E–A (E–G) dipeptides in the EoV polyproteins; however,
none of them could serve as cleavage sites for EoV 3CL, a ﬁnding
similar to observations reported for 3CL protease of a coronavirus,
infectious bronchitis virus (IBV) (Liu et al., 1997). Although the
mechanism for this discrimination is still unclear, unfavorable
secondary structures might be involved. The observation that
cleavage occurs more efﬁciently at certain sites might represent a
possible regulatory mechanism for protease activity during viral
replication.
Similar to chymotrypsin, most of the 3C and 3CL proteases
have a catalytic triad consisting of His, Asp/Glu, and Cys/Ser.
(Dougherty and Semler, 1993; Gorbalenya et al., 1989). The data
presented here suggest that the residues Cys-2383 and His-2261
are essential for protease activity, and the substitution of
Asp-2299 with Ala reduced but did not abolish the processing
activity of EoV 3CL. This ﬁnding suggests that Asp-2299 plays a
supportive but not an essential role. One possibility is that this
residue is close to the substrate-binding pocket and interacts with
essential amino acids (like His-2261) instead of directly binding
to the cleavage sites (Craik et al., 1987; Sprang et al., 1987).
The non-essential roles of Asp were previously reported for
other chymotrypsin-like proteases, such as equine arteritis virus
nsp4 (Asp-1129), equine torovirus Mpro (Glu-3347), and white
bream virus MPro (Asp-3518) (Smits et al., 2006; Snijder et al.,
1996; Ulferts et al., 2011). Further structural studies should be
able to reveal the exact role of Asp-2299 in the EoV 3CL protease.
Like many picornaviral proteases, the EoV 3CL protease con-
tains a cysteine residue as a nucleophile of the active site, and
thus should be sensitive to sulfhydryl reagents (Ryan and Flint,
1997). As expected, the addition of Hg2þ , Zn2þ , and sulfhydryl
reagents such as PCMBS, MMTS, and NEM strongly inhibited
EoV 3CL protease activity thereby conﬁrming the ﬁnding that
Cys-2383 is required for the catalysis of polyprotein processing
and that EoV 3CL is a cysteine protease. On the other hand, the
serine protease inhibitor PMSF also reduced the activity of EoV
3CL, but to a lesser extent (Fig. 7F). Similarly, several other 3C and
3CL cysteine proteases, such as Chiba virus 3CL protease and
poliovirus 3C protease have also been reported to be inhibited by
PMSF (Baum et al., 1991; Someya et al., 2005). This phenomenon
may exist because 3C and 3CL proteases share the structural
homology of chymotrypsin-like folds and have a proteolytic
mechanism similar to that of serine proteases.
Like the 3CL proteases of norovirus and EAV, the EoV 3CL
protease is relatively sensitive to varying Naþ ionic concentra-
tions (Someya et al., 2005; van Aken et al., 2006), because high
concentrations of Naþ strongly inhibited the proteolytic activity
of EoV 3CL. In contrast, the 3CL proteases of mouse hepatitis virus
and porcine reproductive and respiratory syndrome virus (PRRSV)
are insensitive to 100–500 mM of Naþ (Seybert et al., 1997; Xu
et al., 2010). Moreover, the presence of Mg2þ or Ca2þ did not
visibly affect the proteolytic activity of EoV 3CL. In addition, we
found that the optimal pH for EoV 3CL is about 7.5 rather than the
acidic pH we previously expected based on the physiological
environment in insect cells. These biochemical features suggest
that the EoV 3CL protease is localized and functions in a limited
environment such as an intracellular organelle within infected
cells. Moreover, instead of the optimal temperature of 27 1C for
insect cell culture, the optimal temperature for the protease
activity of EoV 3CL is around 22 1C, which corresponds well to
the appropriate environments for the growth of the natural host
of EoV, the tea looper (Ectropis oblique, 20–24 1C). In nature, the
growth and reproduction of tea loopers are greatly affected by
various meteorologic factors, and the temperature is one of the
most important factors (Xue et al., 2009).
For viruses in the order Picornavirales, 3C or 3CL proteases play
essential roles in processing the single open reading frame-encoded large precursor polyproteins into mature functional viral
proteins. In Iﬂaviridae, which is a novel family in the order
Picornavirales, the complete nucleotide sequences of several
iﬂaviruses have been determined and the presence of putative
3CL protease domains have been predicted on the basis of
sequence analysis, but no data have been reported concerning
the characteristics of the putative 3CL proteases and the proces-
sing of iﬂaviral polyproteins.
To our knowledge, our study is the ﬁrst to identify an iﬂaviral
3CL protease, EoV 3CL, and to provide a detailed characterization
of this novel 3CL protease, which not only represents an impor-
tant step toward understanding the mechanism of EoV polypro-
tein proteolytic processing but also gives direction for future
studies of 3CL proteases, polyprotein processing, and viral repli-
cation of other members of the family Iﬂaviridae. For instance, on
the basis of sequence analysis and our ﬁndings, future studies
could ﬁnd conservative residues similar to those at EoV cleavage
sites in other iﬂaviruses, such as the potential cleavage sites
E2192/A2193 and Q2491/S2492 in PnV and Q2178/S2179 and E2446/G2447
in IFV.
As a newly established family within the order Picornavirales,
the family Iﬂaviridae comprises invertebrate viruses belonging to
the picornavirus ‘‘superfamily.’’ Iﬂaviruses share a number of
features, such as virion structure and genomic organization, with
the viruses in the families Picornaviridae and Dicistroviridae but
still form a distinct group of viruses according to phylogenetic
analyses (Le Gall et al., 2008). Thus, detailed molecular studies of
iﬂaviruses like the current study of EoV 3CL might provide novel
insights into biological features of different viruses in the order
Picornavirales and, possibly, help uncover evolutional driving
forces in this group of positive-strand RNA viruses.Materials and methods
Construction of recombinant plasmids and site-directed mutagenesis
The construction of recombinant plasmids was done according
to our standard cloning procedures (Lin et al., 2010). The EoV full-
length genomic cDNA clone obtained previously was used as the
template. The corresponding cDNA sequences were ampliﬁed via
polymerase chain reaction (PCR) and subsequently subcloned into
plasmids such as pET32a, pET28a (Novagen), and pGEX-6p-1 (GE
Healthcare) to generate the bacterial expression vectors for
various fusion proteins. The inserted cDNA sequences, PCR
primers, restriction endonuclease sites, and generated fusion
proteins are listed in Supplementary Table 1. The point mutations
were introduced into the corresponding templates via PCR-
mediated mutagenesis, with appropriate primers containing the
desired nucleotide changes (Table 1).Production of EoV 3CL-speciﬁc polyclonal antibodies
Recombinant 3CL-His was produced and puriﬁed according to
our standard procedures as previously described (Lin et al., 2010)
with minor modiﬁcations. As the expressed 3CL-His was found in
the insoluble fraction of the bacterial lysates, the insoluble
material was collected via centrifugation. The pellet was washed
with 2 M urea and then extracted with the buffer containing
25 mM Tris–HCl, 50 mM NaCl and 8 M urea (pH 7.5) by stirring at
room temperature for 1 h. The resulting supernatant was puriﬁed
using afﬁnity chromatography on Ni–NTA columns (GE Health-
care) according to the manufacturer’s protocol (Fig. 3B). This
puriﬁed protein was used to raise EoV 3CL-speciﬁc polyclonal
rabbit antisera. 3CL-speciﬁc antisera were obtained after
Tablee 1
List of the primers.
Primers Sequence (50–30)
His-Pro2160–2680-Flag-For CCGGAATTCATGTCATTTATTTTTAGTAACAT (EcoRI)
His-Pro2160–2680-Flag-Rev CCGCTCGAGTTACTTGTCATCGTCGTCCTTGTAGTCATCTATACCTACGGCAATTTTATTG (XhoI)
His-Pro2026–2738-Flag-For CCGGAATTCAAGGTGATTCTTCCAGTTGTGTG (EcoRI)
His-Pro2026–2738-Flag-Rev CCGCTCGAGTTACTTGTCATCGTCGTCCTTGTAGTCAACCACATCCTCATACTCCTTGTCT (XhoI)
GST-Pro2176–2677-His-For CCGGAATTCTTGGCCTATAAGGTATATCGTT (EcoRI)
GST-Pro2176–2677-His-Rev CCGCTCGAGTTAGTGATGATGATGATGATGTACGGCAATTTTATTGTTGATGGTG (XhoI)
His-Pro2160–2492-For CCGGAATTCATGTCATTTATTTTTAGTAACAT (EcoRI)
His-Pro2160–2492-Rev CCGCTCGAGTTACTGTGCAGCAGGGATCCGAAAG (XhoI)
His-Pro2026–2492-For CCGGAATTCAAGGTGATTCTTCCAGTTGTGTG (EcoRI)
His-Pro2026–2492-Rev CCGCTCGAGTTACTGTGCAGCAGGGATCCGAAAG (XhoI)
His-3C3D0-For CCGGAATTCGCGCAAGCAAAGGATTACGACCAG (EcoRI)
His-3C3D0-Rev CCGCTCGAGTTAATCTATACCTACGGCAATTTTA (XhoI)
His-3CL-For CCGGAATTCGCGCAAGCAAAGGATTACGACCAG (EcoRI)
His-3CL-Rev CCGCTCGAGTTACTGTGCAGCAGGGATCCGAAAG (XhoI)
3CL-His-For CATGCCATGGGCGCGCAAGCAAAGGATTACGA (NcoI)
3CL-His-Rev CCGCTCGAGTTAGTGATGATGATGATGATGCTGTGCAGCAGGGATCCGAAAGG (XhoI)
nC2383A-For GGGGGCCCAATCCGTAAGGgctGGC
nC2383A-Rev CTCATGATGAGGGAGCCagcCCTTA
nH2261A-For CTTTGTTTTGGCCCCCCAGgctTTA
nH2261A-Rev CGCCGGGCACCCAAGCTAAagcCTG
nD2299A-For CTCTTGTGTTAAAGGATTTgctTAT
nD2299A-Rev CGAACCGGTAGACTGCATAagcAAA
nQ2492A-For CTTTCGGATCCCTGCTGCAgctTCT
nQ2492A-Rev CGCCTTTCGCTGTTGCAGAagcTGC
nE2193A-For TAATTCATCAGAGTGCGTTgctGCG
nE2193A-Rev CGTAATCCTTTGCTTGCGCagcAAC
Sequence-speciﬁc primers are designed according to GenBank accession numbers AY365064 (EoV), and primers with asterisks are designed
for overlapping PCR. Underlined characters indicate restriction endonuclease sites, and the types are shown in parentheses. Substituted
nucleotides for mutagenesis are shown with lowercase characters. Stop code are shown in bold faced characters and the His-tag and Flag-
tag are shown in italics.
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detailed method was previously described (Satheshkumar et al.,
2004).
Proteolytic reaction and trans-cleavage assays
For the proteolytic reaction assay, corresponding recombinant
proteins were expressed in E. coli BL21 (DE3) at 37 1C, and the
cells were harvested after 6 h of incubation in the presence of
1 mM IPTG at 30 1C. The pellet was resuspended in lysis buffer
(25 mM Tris (pH 7.5), 50 mM NaCl, 0.2% TritonX-100, and 5%
glycerol) and then subjected to sonication to generate a total
bacterial lysate. The lysate was then subjected to 12% SDS-PAGE
and Western blotting according to our standard procedures (Lin
et al., 2010; Qiu et al., 2011). For Western blotting, monoclonal
anti-His and anti-Flag antibodies were used as primary antibodies
at a 1:2000 dilution, and a rabbit anti-3CL polyclonal antiserum
that was described above was used at a dilution of 1:1000. The
secondary antibody, alkaline phosphatase-linked goat anti-mouse
immunoglobulin G (IgG), was used at a 1:2000 dilution, or goat
anti-mouse IgG-HRP was used at a 1:10000 dilution (Roche).
For the trans-cleavage assay, recombinant His-3CL, His-3C3D0
(C2383A), and His-3CL(C2383A) were expressed and puriﬁed as
previously described (Lin et al., 2010). Puriﬁed proteins were then
concentrated using Amicon Ultra-30 ﬁlters (Millipore) and stored
in 50 mM NaCl and 25 mM Tris–HCl (pH 7.5) at 70 1C (Qi et al.,
2011, 2012). All proteins were quantiﬁed using a UV–visible
spectrophotometer (Shimadzu, Kyoto, Japan). The recombinant
His-Pro2026–2738-Flag(C2383-A) and His-Pro2160–2680-Flag(C2383-
A) polyproteins were expressed in E. coli BL21 in an insoluble
fraction, which was then resuspended in 50 mM NaCl and 25 mM
Tris–HCl (pH 7.5) after centrifugation. The puriﬁed His-3CL or
negative control His-3CL(C2383A) was incubated with corre-
sponding substrates at a ratio of 2:5. The cleavage reactions were
performed for 6 h at 22 1C in a total volume of 20 ml buffer(25 mM Tris–HCl (pH 7.5), 50 mM NaCl, and 0.25 mM DTT). The
reaction was stopped by boiling with SDS-PAGE loading dye, and
the proteins were then analyzed via 12% SDS-PAGE. Then the gels
were stained with Coomassie brilliant blue R-250. To estimate the
efﬁciency of proteolytic cleavage, the density of the respective
stained bands was scanned and calculated using Bio-Rad Quantity
One software.N-terminal sequencing analysis of cleavage products
The fusion protein GST-Pro2176–2677-His was puriﬁed from
inclusion bodies under denatured conditions according to our
standard method described for production of EoV 3CL-speciﬁc
polyclonal antibodies. The puriﬁed proteins were separated via
12% SDS-PAGE, and the gels were soaked in Western blotting
transfer buffer (10 mM 3-cyclohexylamino-1-propanesulfonic
acid (pH 11), 20% methanol) for 20 min, and then subjected to
eletroblotting via polyvinylidene ﬂuoride membrane (Millipore).
After transfer, the membrane were stained with Coomassie
brilliant blue R250 for 1 min and washed with 30% (vol/vol)
methanol–10% (vol/vol) acetic acid. The two appropriate mem-
brane segments were cut out and subjected to Edman degradation
using a 492 PROCISE protein sequencer (Shanghai GeneCore Bio
Technologies).Acknowledgments
We thank Mr. Huihui He for his help in protein alignment
analysis.
This work was supported by the Chinese 111 project (Grant
B06018), the National Natural Science Foundation of China (Grant
30670084) and the Natural Science Foundation of Hubei Province
(Grant 2011CDB444).
S. Ye et al. / Virology 428 (2012) 136–145 145Referencces
Allaire, M., Chernaia, M.M., Malcolm, B.A., James, M.N., 1994. Picornaviral 3C
cysteine proteinases have a fold similar to chymotrypsin-like serine protei-
nases. Nature 369, 72–76.
Bablanian, G.M., Grubman, M.J., 1993. Characterization of the foot-and-mouth
disease virus 3C protease expressed in Escherichia coli. Virology 197, 320–327.
Baum, E.Z., Bebernitz, G.A., Palant, O., Mueller, T., Plotch, S.J., 1991. Puriﬁcation,
properties, and mutagenesis of poliovirus 3C protease. Virology 185, 140–150.
Blakeney, S.J., Cahill, A., Reilly, P.A., 2003. Processing of Norwalk virus nonstruc-
tural proteins by a 3C-like cysteine proteinase. Virology 308, 216–224.
Bonderoff, J.M., Larey, J.L., Lloyd, R.E., 2008. Cleavage of poly(A)-binding protein by
poliovirus 3C proteinase inhibits viral internal ribosome entry site-mediated
translation. J. Virol. 82, 9389–9399.
Carrier, K., Hans, F., Sanfacon, H., 1999. Mutagenesis of amino acids at two tomato
ringspot nepovirus cleavage sites: effect on proteolytic processing in cis and in
trans by the 3C-like protease. Virology 258, 161–175.
Christian, P., Carstens, E., Domier, L., Johnson, K., Nakashima, N., Scotti, P., van derWilk,
F., 2005. Iﬂavirus. In: Fauquet, C.M., Mayo, M.A., Maniloff, J., Desselberger, U., Ball.,
L.A. (Eds.), Virus Taxonomy: Eighth Report of the International Committee on the
Taxonomy of Viruses. Academic Press, San Diego, USA, pp. 779–782.
Craik, C.S., Roczniak, S., Largman, C., Rutter, W.J., 1987. The catalytic role of the
active site aspartic acid in serine proteases. Science 237, 909–913.
Cui, S., Wang, J., Fan, T., Qin, B., Guo, L., Lei, X., Wang, J., Wang, M., Jin, Q., 2011. Crystal
structure of human enterovirus 71 3C protease. J. Mol. Biol. 408, 449–461.
de Breyne, S., Bonderoff, J.M., Chumakov, K.M., Lloyd, R.E., Hellen, C.U., 2008.
Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases.
Virology 378, 118–122.
Dougherty, W.G., Semler, B.L., 1993. Expression of virus-encoded proteinases:
functional and structural similarities with cellular enzymes. Microbiol. Rev.
57, 781–822.
Ghildyal, R., Jordan, B., Li, D., Dagher, H., Bardin, P.G., Gern, J.E., Jans, D.A., 2009.
Rhinovirus 3C protease can localize in the nucleus and alter active and passive
nucleocytoplasmic transport. J. Virol. 83, 7349–7352.
Ghosh, R.C., Ball, B.V., Willcocks, M.M., Carter, M.J., 1999. The nucleotide sequence
of sacbrood virus of the honey bee: an insect picorna-like virus. J. Gen. Virol.
80 (Pt 6), 1541–1549.
Goodwin, S., Tuthill, T.J., Arias, A., Killington, R.A., Rowlands, D.J., 2009. Foot-and-
mouth disease virus assembly: processing of recombinant capsid precursor by
exogenous protease induces self-assembly of pentamers in vitro in a myr-
istoylation-dependent manner. J. Virol. 83, 11275–11282.
Gorbalenya, A.E., Blinov, V.M., Donchenko, A.P., 1986. Poliovirus-encoded protei-
nase 3C: a possible evolutionary link between cellular serine and cysteine
proteinase families. FEBS Lett. 194, 253–257.
Gorbalenya, A.E., Donchenko, A.P., Blinov, V.M., Koonin, E.V., 1989. Cysteine
proteases of positive strand RNA viruses and chymotrypsin-like serine
proteases. A distinct protein superfamily with a common structural fold. FEBS
Lett. 243, 103–114.
Harmon, S.A., Updike, W., Jia, X.Y., Summers, D.F., Ehrenfeld, E., 1992. Polyprotein
processing in cis and in trans by hepatitis A virus 3C protease cloned and
expressed in Escherichia coli. J. Virol. 66, 5242–5247.
Isawa, H., Asano, S., Sahara, K., Iizuka, T., Bando, H., 1998. Analysis of genetic
information of an insect picorna-like virus, infectious ﬂacherie virus of silk-
worm: evidence for evolutionary relationships among insect, mammalian and
plant picorna(-like) viruses. Arch. Virol. 143, 127–143.
Lanzi, G., de Miranda, J.R., Boniotti, M.B., Cameron, C.E., Lavazza, A., Capucci, L.,
Camazine, S.M., Rossi, C., 2006. Molecular and biological characterization of
deformed wing virus of honeybees (Apis mellifera L.). J. Virol. 80, 4998–5009.
Lawson, T.G., Gronros, D.L., Evans, P.E., Bastien, M.C., Michalewich, K.M., Clark, J.K.,
Edmonds, J.H., Graber, K.H., Werner, J.A., Lurvey, B.A., Cate, J.M., 1999.
Identiﬁcation and characterization of a protein destruction signal in the
encephalomyocarditis virus 3C protease. J. Biol. Chem. 274, 9904–9980.
Le Gall, O., Christian, P., Fauquet, C.M., King, A.M., Knowles, N.J., Nakashima, N.,
Stanway, G., Gorbalenya, A.E., 2008. Picornavirales, a proposed order of
positive-sense single-stranded RNA viruses with a pseudo-T¼3 virion archi-
tecture. Arch. Virol. 153, 715–727.
Lin, C.W., Tsai, C.H., Tsai, F.J., Chen, P.J., Lai, C.C., Wan, L., Chiu, H.H., Lin, K.H., 2004.
Characterization of trans- and cis-cleavage activity of the SARS coronavirus
3CLpro protease: basis for the in vitro screening of anti-SARS drugs. FEBS Lett.
574, 131–137.
Lin, M., Ye, S., Xiong, Y., Cai, D., Zhang, J., Hu, Y., 2010. Expression and
characterization of RNA-dependent RNA polymerase of Ectropis obliqua virus.
BMB Rep. 43, 284–290.
Liu, D.X., Xu, H.Y., Brown, T.D., 1997. Proteolytic processing of the coronavirus
infectious bronchitis virus 1a polyprotein: identiﬁcation of a 10-kilodalton
polypeptide and determination of its cleavage sites. J. Virol. 71, 1814–1820.
Lu, G., Qi, J., Chen, Z., Xu, X., Gao, F., Lin, D., Qian, W., Liu, H., Jiang, H., Yan, J., Gao, G.F.,
2011. Enterovirus 71 and coxsackievirus A16 3C proteases: binding to rupintrivir
and their substrates and anti-hand, foot, and mouth disease virus drug design. J.
Virol. 85, 10319–10331.
Lu, J., Hu, Y., Hu, L., Zong, S., Cai, D., Wang, J., Yu, H., Zhang, J., 2007. Ectropis
obliqua picorna-like virus IRES-driven internal initiation of translation in cell
systems derived from different origins. J. Gen. Virol. 88, 2834–2838.Lu, J., Zhang, J., Wang, X., Jiang, H., Liu, C., Hu, Y., 2006. In vitro and in vivo
identiﬁcation of structural and sequence elements in the 50 untranslated
region of Ectropis obliqua picorna-like virus required for internal initiation. J.
Gen. Virol. 87, 3667–3677.
Malcolm, B.A., 1995. The picornaviral 3C proteinases: cysteine nucleophiles in
serine proteinase folds. Protein Sci. 4, 1439–1445.
Matthews, D.A., Smith, W.W., Ferre, R.A., Condon, B., Budahazi, G., Sisson, W.,
Villafranca, J.E., Janson, C.A., McElroy, H.E., Gribskov, C.L., et al., 1994. Structure
of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-
binding site, and means for cleaving precursor polyprotein. Cell 77, 761–771.
Ongus, J.R., Peters, D., Bonmatin, J.M., Bengsch, E., Vlak, J.M., van Oers, M.M., 2004.
Complete sequence of a picorna-like virus of the genus Iﬂavirus replicating in
the mite Varroa destructor. J. Gen. Virol. 85, 3747–3755.
Palmenberg, A.C., 1990. Proteolytic processing of picornaviral polyprotein. Annu.
Rev. Microbiol. 44, 603–623.
Qi, N., Cai, D., Qiu, Y., Xie, J., Wang, Z., Si, J., Zhang, J., Zhou, X., Hu, Y., 2011. RNA
binding by a novel helical fold of b2 protein from Wuhan. Nodavirus mediates
the suppression of RNA interference and promotes b2 dimerization. J. Virol. 85,
9543–9554.
Qi, N., Zhang, L., Qiu, Y., Wang, Z., Si, J., Liu, Y., Xiang, X., Xie, J., Qin, C.F., Zhou, X.,
Hu, Y., 2012. Targeting of Dicer-2 and RNA by a viral RNA silencing suppressor
in Drosophila cells. J. Virol.. (Epub, 10.1128/jvi.07229-11).
Qiu, Y., Cai, D., Qi, N., Wang, Z., Zhou, X., Zhang, J., Hu, Y., 2011. Internal initiation is
responsible for synthesis of Wuhan nodavirus subgenomic RNA. J. Virol. 85,
4440–4451.
Rivera, C.I., Lloyd, R.E., 2008. Modulation of enteroviral proteinase cleavage of
poly(A)-binding protein (PABP) by conformation and PABP-associated factors.
Virology 375, 59–72.
Robel, I., Gebhardt, J., Mesters, J.R., Gorbalenya, A., Coutard, B., Canard, B.,
Hilgenfeld, R., Rohayem, J., 2008. Functional characterization of the cleavage
speciﬁcity of the sapovirus chymotrypsin-like protease. J. Virol. 82,
8085–8093.
Ryan, M.D., Flint, M., 1997. Virus-encoded proteinases of the picornavirus super-
group. J. Gen. Virol. 78 (Pt 4), 699–723.
Satheshkumar, P.S., Lokesh, G.L., Savithri, H.S., 2004. Polyprotein processing: cis
and trans proteolytic activities of Sesbania mosaic virus serine protease.
Virology 318, 429–438.
Seybert, A., Ziebuhr, J., Siddell, S.G., 1997. Expression and characterization of a
recombinant murine coronavirus 3C-like proteinase. J. Gen. Virol. 78 (Pt 1),
71–75.
Smits, S.L., Snijder, E.J., de Groot, R.J., 2006. Characterization of a torovirus main
proteinase. J. Virol. 80, 4157–4167.
Snijder, E.J., Wassenaar, A.L., van Dinten, L.C., Spaan, W.J., Gorbalenya, A.E., 1996.
The arterivirus nsp4 protease is the prototype of a novel group of chymo-
trypsin-like enzymes, the 3C-like serine proteases. J. Biol. Chem. 271,
4864–4871.
Someya, Y., Takeda, N., Miyamura, T., 2005. Characterization of the norovirus 3C-
like protease. Virus Res. 110, 91–97.
Sprang, S., Standing, T., Fletterick, R.J., Stroud, R.M., Finer-Moore, J., Xuong, N.H.,
Hamlin, R., Rutter, W.J., Craik, C.S., 1987. The three-dimensional structure of
Asn102 mutant of trypsin: role of Asp102 in serine protease catalysis. Science
237, 905–909.
Sweeney, T.R., Roque-Rosell, N., Birtley, J.R., Leatherbarrow, R.J., Curry, S., 2007.
Structural and mutagenic analysis of foot-and-mouth disease virus 3C
protease reveals the role of the beta-ribbon in proteolysis. J. Virol. 81,
115–124.
Tian, X., Lu, G., Gao, F., Peng, H., Feng, Y., Ma, G., Bartlam, M., Tian, K., Yan, J.,
Hilgenfeld, R., Gao, G.F., 2009. Structure and cleavage speciﬁcity of the
chymotrypsin-like serine protease (3CLSP/nsp4) of Porcine Reproductive and
Respiratory Syndrome Virus (PRRSV). J. Mol. Biol. 392, 977–993.
Ulferts, R., Mettenleiter, T.C., Ziebuhr, J., 2011. Characterization of Baﬁnivirus main
protease autoprocessing activities. J. Virol. 85, 1348–1359.
van Aken, D., Benckhuijsen, W.E., Drijfhout, J.W., Wassenaar, A.L., Gorbalenya, A.E.,
Snijder, E.J., 2006. Expression, puriﬁcation, and in vitro activity of an arter-
ivirus main proteinase. Virus Res. 120, 97–106.
van Oers, M.M., 2010. Genomics and biology of Iﬂaviruses. In: Asgari, S., Johnson,
K. (Eds.), Insect Virology. Caister Academic Press, Norﬂok, UK, pp. 231–250.
Wang, X., Zhang, J., Lu, J., Yi, F., Liu, C., Hu, Y., 2004. Sequence analysis and genomic
organization of a new insect picorna-like virus, Ectropis obliqua picorna-like
virus, isolated from Ectropis obliqua. J. Gen. Virol. 85, 1145–1151.
Wu, C.Y., Lo, C.F., Huang, C.J., Yu, H.T., Wang, C.H., 2002. The complete genome
sequence of Perina nuda picorna-like virus, an insect-infecting RNA virus with
a genome organization similar to that of the mammalian picornaviruses.
Virology 294, 312–323.
Xu, A.T., Zhou, Y.J., Li, G.X., Yu, H., Yan, L.P., Tong, G.Z., 2010. Characterization of the
biochemical properties and identiﬁcation of amino acids forming the catalytic
center of 3C-like proteinase of porcine reproductive and respiratory syndrome
virus. Biotechnol. Lett. 32, 1905–1910.
Xue, D., Wu, Y., Cao, L., Wang, J., 2009. The relationship between the growth of
Ectropis oblique and the natural environment condition. Mod. Agric. Sci.
Technol., 146–149.
Ypma-Wong, M.F., Filman, D.J., Hogle, J.M., Semler, B.L., 1988. Structural domains
of the poliovirus polyprotein are major determinants for proteolytic cleavage
at Gln–Gly pairs. J. Biol. Chem. 263, 17846–17856.
